These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 1615119)

  • 1. Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.
    Sarter M; Hagan J; Dudchenko P
    Psychopharmacology (Berl); 1992; 107(2-3):144-59. PubMed ID: 1615119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical research into cognition enhancers.
    Sarter M
    Trends Pharmacol Sci; 2006 Nov; 27(11):602-8. PubMed ID: 16997388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.
    Sarter M; Hagan J; Dudchenko P
    Psychopharmacology (Berl); 1992; 107(4):461-73. PubMed ID: 1603889
    [No Abstract]   [Full Text] [Related]  

  • 4. Taking stock of cognition enhancers.
    Sarter M
    Trends Pharmacol Sci; 1991 Dec; 12(12):456-61. PubMed ID: 1792689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral Experimental Paradigms for the Evaluation of Drug's Influence on Cognitive Functions: Interpretation of Associative, Spatial/Nonspatial and Working Memory.
    Zameer S; Akhtar M; Vohora D
    CNS Neurol Disord Drug Targets; 2019; 18(3):185-204. PubMed ID: 30648527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of behavioral tests to assess the effects of cognitive enhancers.
    Olton DS; Wenk L
    Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():65-9. PubMed ID: 2186416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of cognitive function.
    Decker MW
    Crit Rev Neurobiol; 1995; 9(4):321-43. PubMed ID: 8829849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological enhancement of memory and executive functioning in laboratory animals.
    Floresco SB; Jentsch JD
    Neuropsychopharmacology; 2011 Jan; 36(1):227-50. PubMed ID: 20844477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The families of cognition enhancers.
    Fröstl W; Maître L
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():54-100. PubMed ID: 2690152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive function.
    Talpos J; Shoaib M
    Handb Exp Pharmacol; 2015; 228():191-213. PubMed ID: 25977083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrichment Effects on Adult Cognitive Development: Can the Functional Capacity of Older Adults Be Preserved and Enhanced?
    Hertzog C; Kramer AF; Wilson RS; Lindenberger U
    Psychol Sci Public Interest; 2008 Oct; 9(1):1-65. PubMed ID: 26162004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems in the search for cognition enhancers.
    Hollister LE
    Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():33-6. PubMed ID: 2186410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacological strategies in the search for cognition enhancers.
    Sanger DJ; Joly D
    Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():70-4. PubMed ID: 2186417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological analyses of learning and memory in zebrafish (Danio rerio).
    Bailey JM; Oliveri AN; Levin ED
    Pharmacol Biochem Behav; 2015 Dec; 139 Pt B(0 0):103-11. PubMed ID: 25792292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy for the assessment of neurobehavioral consequences of environmental factors.
    Tilson HA; Cabe PA
    Environ Health Perspect; 1978 Oct; 26():287-99. PubMed ID: 720319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
    Brown JW; Rueter LE; Zhang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.
    Barak S; Weiner I
    Pharmacol Biochem Behav; 2011 Aug; 99(2):164-89. PubMed ID: 21420999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive enhancers: potential strategies and experimental results.
    Wenk GL; Olton DS
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S117-39. PubMed ID: 2694226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predicting the psychotropic properties of new drugs on the basis of drug screening in animals].
    Kostowski W
    Psychiatr Pol; 1976; 10(1):33-43. PubMed ID: 1250903
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary on: "comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse." Psychopharmacologia (1968) 13: 222-257.
    Warburton DM
    Psychopharmacology (Berl); 2002 Aug; 163(1):4-8. PubMed ID: 12238442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.